Senator Bernie Sanders wants to meet next week with Novo Nordisk A/S’s top executive about lowering the price of its blockbuster drug Ozempic, fueling controversy over the costs of GLP-1 drugs for diabetes and obesity.
The Vermont independent said he’s considering hearings on the cost of GLP-1 drugs like Ozempic, but first wants to personally discuss their prices with Novo Chief…
